| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871475 | The Annals of Thoracic Surgery | 2016 | 8 Pages |
Abstract
An increase in glucose avidity of non-small cell lung cancers during induction therapy was associated with a worse prognosis compared with stable or any decrease in standardized uptake value. Changes in the glucose avidity of mediastinal nodal metastases may be a stronger predictor of survival than changes in the primary site of disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Stephen A. MBBS, Robert J. MD, Junting MS, Gabriel BS, Ronglai PhD, Jamie MD, Timothy MBBS, Bernard J. MD, Valerie W. MD,